Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | ITGB3 | P05106 | 12/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 12/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.50 |
| ▸ | NHERF1 | O14745 | 1/20 | 0.46 |
| ▸ | PLD2 | O14939 | 1/20 | 0.45 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5889476 | 0.91 | KDM4E (0.61) | KDM4EHSD17B10ITGB3ITGA2BHDAC2 | |
| SCHEMBL5896783 | 0.90 | ITGB3 (0.58) | KDM4EHSD17B10ITGB3ITGA2BHDAC2 | |
| SCHEMBL5677265 | 0.87 | ITGB3 (0.54) | KDM4EHSD17B10ITGB3ITGA2BHDAC2 | |
| SCHEMBL5889528 | 0.84 | PYGL (0.48) | KDM4EITGB3ITGA2BHDAC2NHERF1 | |
| SCHEMBL5889537 | 0.84 | KDM4E (0.51) | KDM4EHSD17B10ITGB3ITGA2BHDAC2 | |
| SCHEMBL5889622 | 0.84 | ITGB3 (0.53) | KDM4EHSD17B10ITGB3ITGA2BHDAC2 | |
| SCHEMBL5889814 | 0.83 | HDAC2 (0.50) | KDM4EHSD17B10ITGB3ITGA2BHDAC2 | |
| SCHEMBL5889574 | 0.83 | KDM4E (0.50) | KDM4EHDAC2NHERF1PLD2PLD1 | |
| SCHEMBL5889931 | 0.82 | TERT (0.53) | KDM4EHSD17B10ITGB3ITGA2BHDAC2 | |
| SCHEMBL5889693 | 0.82 | HRH4 (0.56) | KDM4EHSD17B10ITGB3ITGA2BHDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7064218-B2 | Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity | GENELABS TECHNOLOGIES, INC. (US) | 2006-06-20 | — | — | US | disclosed |
| US-20030212113-A1 | Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity | GLAXOSMITHKLINE LLC | 2003-11-13 | — | — | US | disclosed |
| WO-2003057212-A1 | POLYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL, ANTIFUNGAL OR ANTITUMOR ACTIVITY | GENELABS TECHNOLOGIES, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030212113-A1 | Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity | TYR, CYP51A1, ODC1 | KDM4E 1515/4885HSD17B10 1184/4885ITGB3 4485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.